1. Home
  2. TBPH vs GHM Comparison

TBPH vs GHM Comparison

Compare TBPH & GHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • GHM
  • Stock Information
  • Founded
  • TBPH 2013
  • GHM 1936
  • Country
  • TBPH United States
  • GHM United States
  • Employees
  • TBPH N/A
  • GHM N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • GHM Industrial Machinery/Components
  • Sector
  • TBPH Health Care
  • GHM Industrials
  • Exchange
  • TBPH Nasdaq
  • GHM Nasdaq
  • Market Cap
  • TBPH 536.5M
  • GHM 527.6M
  • IPO Year
  • TBPH N/A
  • GHM N/A
  • Fundamental
  • Price
  • TBPH $11.15
  • GHM $52.75
  • Analyst Decision
  • TBPH Strong Buy
  • GHM Strong Buy
  • Analyst Count
  • TBPH 5
  • GHM 2
  • Target Price
  • TBPH $16.60
  • GHM $60.00
  • AVG Volume (30 Days)
  • TBPH 245.1K
  • GHM 139.9K
  • Earning Date
  • TBPH 08-04-2025
  • GHM 08-06-2025
  • Dividend Yield
  • TBPH N/A
  • GHM N/A
  • EPS Growth
  • TBPH N/A
  • GHM 164.29
  • EPS
  • TBPH N/A
  • GHM 1.11
  • Revenue
  • TBPH $65,266,000.00
  • GHM $209,896,000.00
  • Revenue This Year
  • TBPH $43.18
  • GHM $10.67
  • Revenue Next Year
  • TBPH N/A
  • GHM $9.35
  • P/E Ratio
  • TBPH N/A
  • GHM $47.52
  • Revenue Growth
  • TBPH 6.11
  • GHM 13.13
  • 52 Week Low
  • TBPH $7.44
  • GHM $24.78
  • 52 Week High
  • TBPH $11.82
  • GHM $52.94
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 62.38
  • GHM 75.13
  • Support Level
  • TBPH $10.87
  • GHM $48.48
  • Resistance Level
  • TBPH $11.44
  • GHM $51.28
  • Average True Range (ATR)
  • TBPH 0.29
  • GHM 1.83
  • MACD
  • TBPH -0.00
  • GHM 0.11
  • Stochastic Oscillator
  • TBPH 71.92
  • GHM 97.61

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About GHM Graham Corporation

Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.

Share on Social Networks: